Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox
 


  Surveillance

The first European project for data collection on influenza was the Eurosentinel Scheme (1987-1991). The European Influenza Surveillance Scheme (EISS) has been operational since 1995 and has received funding from the European Commission since November 1999. The overall objectives of the EISS are to facilitate the rapid exchange of information on influenza activity in Europe, to combine clinical and virological data in the same population, to identify causal viruses in the population, to recognize virological changes, and to provide standardized high quality information.

Flu-related data such as hospitalizations, number of cases and consultations, isolated subtypes or strains, and geographical distribution are collected by physicians throughout Europe and are evaluated and published on a weekly basis.

Currently, data of the following 23 countries are available: Austria, Belgium, the Czech Republic, Denmark, France, Germany, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, the Slovak Republic, Slovenia, Spain, Sweden, Switzerland and the United Kingdom. Scotland and Wales run their own influenza surveillance networks, yet they still contribute data.

If you want to follow the spread of Influenza from week to week throughout Europe, please visit their website at
http://www.eiss.org


 » Printversion

 
 
  » find


 

Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,